Search results for: 'Global Precision Oncology Market Trends and Growth Opportunities'
- Related search terms
- global market for smart handheld metrology devices forecast to 2023 industry research analysis made measurement amp instrumentation
- growth projections for european facility (management re) future of facility management forecast to 2025 t market forecasts to 2025
- global water atomized copper powder market report 2020 by key players types applications countries market size forecast to 2026 based on 2020 covid19 worldwide spread
- growth opportunities from decarbonization ingrowth opportunities from decarbonization in the global power marker the global power
- growth opportunities driven by ecosystem and (se(service based) models in home automation
-
22 May 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Advanced RNA Therapies, Cancer Vaccines, Immunotherapies, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...
$950.00 -
30 Sep 2026  |  Global  |  Market Research
Global Economic Transformations for 2026 (Q3 Update)
US-Iran Conflict to Slow Global Growth to 2.5% in H2 2026; AI Investments and Asian Tech Exports Drive Resilience
Prolonged geopolitical uncertainty, elevated energy costs, and persistent supply chain and trade disruptions define global economic conditions in Q3 2026. The US-Iran conflict has materially weakened the global growth trajectory, shaving 0.6 percentage points from the 2026 outlook (vs 3.5% in 2025) and slowing global GDP growth to 2.5% in Q3 2026, ...
$2,450.00 -
03 Jan 2024  |  Global  |  Market Research
Top 5 Growth Opportunities for the Pharmaceutical Industry, 2024
Tech-enabled Partnerships Propelling Drug Discovery and Development in Precision Oncology, Rare Diseases, and Obesity
In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...
$2,450.00 -
26 Sep 2011  |  Global  |  Technology Research
Radiation Oncology--Funding Trend Analysis (Technical Insights)
Radiation Oncology - Promising technologies providing a ray of hope for cancer.
This research service analyzes the funding scenario in radiation oncology industry sector and provides insights to investors for potential investments into promising technologies and offers strategic recommendations for firms for procuring funds. The study offers strategic analysis and insights on potential technologies worthy of investment and com...
$4,950.00 -
16 Nov 2023  |  Global  |  Technology Research
Technology Growth Opportunities for Precision Fermentation
Competitive Intensity Enabling Emergence of New High-impact Sustainable Ingredients for Diverse Industries
Conventional fermentation has long been in use, especially for food production. Fermentation applications have expanded to the production of alternate proteins and other ingredients. Traditional fermentation employs microorganisms in their natural state to produce bio-based ingredients for industrial chemicals, biomaterials, pharmaceuticals, food a...
$4,950.00 -
17 Apr 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Advanced Biologic Therapies, AI-powered Diagnostics, Drug Delivery Platforms, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...
$950.00 -
08 Sep 2016  |  Global  |  Market Research
Growth Opportunities for Healthcare Big Data—An Analysis of Global Case Studies
Big Data Initiatives Targeted at Health Prediction and Precision
The healthcare industry has been a laggard in Big Data adoption as compared to other verticals and continues to battle challenges around interoperability, budget constraints, and insufficient strategic planning and change management. However, the intent to leverage the power of Big Data is evident across all industry stakeholders, including governm...
$1,500.00 -
11 Jul 2023  |  Global  |  Megatrends
Trend Opportunity Profile Series: Future of Work
Transformative Mega Trends Enabling Growth and Innovation Till 2030
Countries across the world have adopted several transformative work trends. This study analyzes how those trends create a better work environment and generate opportunities for major sectors, such as technology, energy, industrial, mobility, business and financial services, agriculture, security, aerospace and defense, supply chain and logistics, r...
$4,950.00 -
20 Feb 2025  |  Global  |  Market Outlook
Top 6 Growth Opportunities in Pharma-Biotech, 2025
Unlocking Growth in Precision Therapeutics, Digital Innovation, Manufacturing, and Emerging Markets
The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatments, particularly in personalized medicine, promis...
$2,450.00 -
13 Dec 2022  |  Global  |  Technology Research
Companion Diagnostics (CDx): Technology Innovation and Growth Opportunities
The Transition to Precision Medicine is Propelling the Adoption of CDx Platforms.
The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...
$4,950.00